Skip to main content
Top
Published in: Molecular Imaging and Biology 2/2011

01-04-2011 | Research Article

Feasibility of Assessing [18F]FDG Lung Metabolism with Late Dynamic PET Imaging

Authors: Eric Laffon, Henri de Clermont, Jean-Marc Vernejoux, Jacques Jougon, Roger Marthan

Published in: Molecular Imaging and Biology | Issue 2/2011

Login to get access

Abstract

Purpose

The aim of this work was to non-invasively establish the feasibility of assessing 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG) lung metabolism with the use of a late dynamic positron emission tomograpy (PET) acquisition, i.e., beyond 2 h after injection.

Procedures

The present method has been probed in 11 patients without any respiratory disease, under fasting conditions, by assessing mean values of 18F-FDG lung metabolism. A kinetic model analysis has been implemented on a simple calculation sheet. An arbitrary (population based) input function has been used in each individual, which was obtained from literature data.

Results

In the healthy lung, no 18F-FDG release was found, and the mean values (±SD) of the 18F-FDG uptake rate constant and of the fraction of the free tracer in blood and interstitial volume were: K = 0.0016 min−1 (±0.0005), and F = 0.18 (±0.10), respectively. These results were in very close agreement with literature data that were obtained by both three-compartment model analysis and Patlak graphical analysis (gold standards), and that used an invasive blood sampling. Furthermore, K and the standard uptake value index have been compared.

Conclusion

We conclude that assessing lung metabolism of 18F-FDG in humans with the use of late dynamic PET imaging is feasible. The arbitrary input function of this non-invasive feasibility study could be replaced in further experiments by an input function obtained by arterial sampling. It is suggested that this method may prove useful to quantify 18F-FDG lung metabolism under pathological conditions.
Literature
1.
go back to reference Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP (1978) Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of 18FDG. J Nucl Med 19:1154–1161PubMed Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP (1978) Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of 18FDG. J Nucl Med 19:1154–1161PubMed
3.
go back to reference Sokoloff L, Reivich M, Kennedy C et al (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albinos rat. J Neurochem 28:897–916PubMedCrossRef Sokoloff L, Reivich M, Kennedy C et al (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albinos rat. J Neurochem 28:897–916PubMedCrossRef
4.
go back to reference Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-Glucose: validation of method. Ann Neurol 6:371–388PubMedCrossRef Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-d-Glucose: validation of method. Ann Neurol 6:371–388PubMedCrossRef
5.
go back to reference Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1–7PubMed Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3:1–7PubMed
6.
go back to reference Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 5:584–590PubMed Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 5:584–590PubMed
7.
go back to reference Hunter GJ, Hamberg LM, Alpert NM, Choi NC, Fischman AJ (1996) Simplified measurement of deoxyglucose utilization rate. J Nucl Med 37:950–955PubMed Hunter GJ, Hamberg LM, Alpert NM, Choi NC, Fischman AJ (1996) Simplified measurement of deoxyglucose utilization rate. J Nucl Med 37:950–955PubMed
8.
go back to reference Vriens D, de Geus-Oei L-F, Oyen WJG, Visser EP (2009) A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment. J Nucl Med 50:1933–1939PubMedCrossRef Vriens D, de Geus-Oei L-F, Oyen WJG, Visser EP (2009) A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment. J Nucl Med 50:1933–1939PubMedCrossRef
9.
go back to reference Alavi A, Gupta N, Alberini JL et al (2002) Positron emission tomography imaging in non-malignant thoracic disorders. Semin Nucl Med 32:293–321PubMedCrossRef Alavi A, Gupta N, Alberini JL et al (2002) Positron emission tomography imaging in non-malignant thoracic disorders. Semin Nucl Med 32:293–321PubMedCrossRef
10.
go back to reference Taylor IK, Hill AA, Hayes M et al (1996) Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography. Lancet 347:937–940PubMedCrossRef Taylor IK, Hill AA, Hayes M et al (1996) Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography. Lancet 347:937–940PubMedCrossRef
11.
go back to reference Jones HA, Marino PS, Morrell NW (2003) In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Resp J 21:567–573CrossRef Jones HA, Marino PS, Morrell NW (2003) In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Resp J 21:567–573CrossRef
12.
go back to reference Chen DL, Mintun MA, Schuster DP (2004) Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury. J Nucl Med 45:1583–1590PubMed Chen DL, Mintun MA, Schuster DP (2004) Comparison of methods to quantitate 18F-FDG uptake with PET during experimental acute lung injury. J Nucl Med 45:1583–1590PubMed
13.
go back to reference Laffon E, Allard M, Marthan R, Ducassou D (2004) A method to quantify the uptake rate of 2-[18F]fluoro-2-deoxy-d-glucose in tissues. Nucl Med Commun 25:851–854PubMedCrossRef Laffon E, Allard M, Marthan R, Ducassou D (2004) A method to quantify the uptake rate of 2-[18F]fluoro-2-deoxy-d-glucose in tissues. Nucl Med Commun 25:851–854PubMedCrossRef
14.
go back to reference Laffon E, Allard M, Marthan R, Ducassou D (2005) A method to quantify at late imaging a release rate of 18F-FDG in tissues. CR Biol 328:767–772CrossRef Laffon E, Allard M, Marthan R, Ducassou D (2005) A method to quantify at late imaging a release rate of 18F-FDG in tissues. CR Biol 328:767–772CrossRef
15.
go back to reference Kubota K, Itoh M, Ozaki K et al (2001) Advantage of delayed whole-body FDG-PET imaging for tumor detection. Eur J Nucl Med 28:696–703PubMedCrossRef Kubota K, Itoh M, Ozaki K et al (2001) Advantage of delayed whole-body FDG-PET imaging for tumor detection. Eur J Nucl Med 28:696–703PubMedCrossRef
Metadata
Title
Feasibility of Assessing [18F]FDG Lung Metabolism with Late Dynamic PET Imaging
Authors
Eric Laffon
Henri de Clermont
Jean-Marc Vernejoux
Jacques Jougon
Roger Marthan
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Molecular Imaging and Biology / Issue 2/2011
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-010-0345-6

Other articles of this Issue 2/2011

Molecular Imaging and Biology 2/2011 Go to the issue